1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/21125
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-07-06T10:17:39Z-
dc.date.available2021-07-06T10:17:39Z-
dc.date.issued2005-08-
dc.identifier.citationAli, R. vd. (2005). "Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML) - Outcome of discontinuation of imatinib therapy after achieving a molecular remission", Leukemia Research, 29(8), 971-973.en_US
dc.identifier.issn0145-2126-
dc.identifier.urihttps://doi.org/10.1016/j.leukres.2005.01.009-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0145212605000536-
dc.identifier.urihttp://hdl.handle.net/11452/21125-
dc.description.abstractBecause of the teratogenicity data in rats, it is recommended that women treated with imatinib should be aware of the potential teratogenicity of imatimb and effective contraception should be used during imatinib therapy to prevent pregnancy. We describe successful pregnancy and delivery, without any congenital anomaly, in a patient with CML under treatment of imatinib. The fetus had been exposed to imatinib for 8 weeks. The patient remained off treatment during gestation and cytogenetic relapse of CML (5 months after discontinuation of imatinib therapy) developed at seventh month of gestation. (c) 2005 Elsevier Ltd. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Scienceen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic myelogenous leukemiaen_US
dc.subjectPregnancyen_US
dc.subjectImatiniben_US
dc.subjectManagementen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.titlePregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML) - Outcome of discontinuation of imatinib therapy after achieving a molecular remissionen_US
dc.typeArticleen_US
dc.identifier.wos000230369800015tr_TR
dc.identifier.scopus2-s2.0-20544435207tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Hematoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Genetik Anabilim Dalı.tr_TR
dc.identifier.startpage971tr_TR
dc.identifier.endpage973tr_TR
dc.identifier.volume29tr_TR
dc.identifier.issue8tr_TR
dc.relation.journalLeukemia Researchen_US
dc.contributor.buuauthorAli, Rıdvan-
dc.contributor.buuauthorÖzkalemkaş, Fahir-
dc.contributor.buuauthorÖzçelik, Tülay-
dc.contributor.buuauthorÖzkocaman, Vildan-
dc.contributor.buuauthorOzan, Ülkü-
dc.contributor.buuauthorKimya, Yalçın-
dc.contributor.buuauthorKöksal, Nilgün-
dc.contributor.buuauthorGülten, Tuna-
dc.contributor.buuauthorYakut, Tahsin-
dc.contributor.buuauthorTunalı, Ahmet-
dc.contributor.researcheridAAH-1854-2021tr_TR
dc.contributor.researcheridAAG-8495-2021tr_TR
dc.identifier.pubmed15978950tr_TR
dc.subject.wosOncologyen_US
dc.subject.wosHematologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2en_US
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.